1
Home
Companies

Atomo Diagnostics

Atomo Diagnostics
Leadership team

Mr. John Michael Kelly (Founder, CEO, MD & Director)

Mr. William Edward Souter BCom, LLB (Adel), IPAA (Chief Financial Officer)

Ms. Chandra Sukumar (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Manufacturing, Medical Device
Number of Employees
0 - 50
Headquarters
Leichhardt, New South Wales, Australia
Established
2010
Revenue
5M - 20M
Traded as
ASX:AT1
Social Media
URL
https://atomodiagnostics.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.
History

Atomo Diagnostics was founded in 2010 and is headquartered in Perth, Australia. Since becoming operational in 2011, Atomo has grown to become a leading provider of rapid diagnostic tests for infectious diseases in fields such as clinical pathology, medical and point-of-care (POC) testing. Atomo’s innovative diagnostic tests are designed to simplify complex diagnostic testing processes in a wide range of medical settings, from rural clinics to high-tech medical laboratories.

Mission
Atomo Diagnostics’ mission is to improve the efficiency, accuracy, and affordability of diagnostic testing with the ultimate goal of improving public health by providing the best possible diagnostic tests to those who need them.
Vision
Atomo Diagnostics envisions a world in which the most advanced and accurate diagnostic tests are available to all, irrespective of economic or geographic circumstances.
Key Team

Mr. Jim P. McMenamy (Head of Bus. Devel. & Partnerships of the Americas)

Ms. Anna Tucker (Head of Bus. Devel. & Partnerships of Europe, Middle East and Africa)

Mr. Tharun Kuppanda (Company Sec.)

Recognition and Awards
Atomo Diagnostics have received several prestigious awards, including the 2016 Frost & Sullivan Global Award for Technology Innovation in Rapid Diagnostic Testing and the 2017 Asia Pacific Frost & Sullivan Award for Corporate Excellence in Innovation. In 2020, Atomo won the Gold Award for Best in Point-of-Care Diagnostics from Frost & Sullivan.
References

https://in.investing.com/equities/atomo-diagnostics-ltd

https://finance.yahoo.com/quote/AT1.AX/profile?p=AT1.AX

https://www.crunchbase.com/organization/atomo-diagnostics

https://atomodiagnostics.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Atomo Diagnostics
Leadership team

Mr. John Michael Kelly (Founder, CEO, MD & Director)

Mr. William Edward Souter BCom, LLB (Adel), IPAA (Chief Financial Officer)

Ms. Chandra Sukumar (Chief Operating Officer)

Products/ Services
Biotechnology, Health Care, Manufacturing, Medical Device
Number of Employees
0 - 50
Headquarters
Leichhardt, New South Wales, Australia
Established
2010
Revenue
5M - 20M
Traded as
ASX:AT1
Social Media
URL
https://atomodiagnostics.com